GlassScriptPhysician profile
Paul Choi
NPI 1962652875
$98,852.65
in general payments reported to CMS, 2019-2025
9 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81K · 2020: $9,435 · 2021: $5,270 · 2023: $2,412 · 2024: $125 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,889 · Food and Beverage: $773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,889.31 |
| Food and Beverage | $772.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $70,239.07 | 2019-2021 | |
| Pfizer INC. | $15,986.80 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $5,529.37 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $2,950.00 | 2019 | |
| Exact Sciences Corporation | $2,494.67 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $1,500.00 | 2020 | |
| Novo Nordisk INC | $120.78 | 2019 | |
| Bausch Health US, LLC | $18.10 | 2023 | Aplenzin, Wellbutrin |
| Sentynl Therapeutics, INC. | $13.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.